Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT".

Details

Language :

English

ISSN :

00097322

Volume :

133

Issue :

13

Database :

Complementary Index

Journal :

Circulation

Publication Type :

Academic Journal

Accession number :

114049935

Full Text :

https://doi.org/10.1161/CIRCULATIONAHA.116.020947